Table 4 Evaluation of clinical efficacy of ZSXBF in the treatment of KOA
Before (\({\overline{\text{x}}} + {\text{s}}\)) | After (\({\overline{\text{x}}} + {\text{s}}\)) | P | |
|---|---|---|---|
VAS | 6.2 ± 1.295 | 2.87 ± 0.849 | 0.000 |
Lequesne | |||
Pain or discomfort | 4.46 ± 1.536 | 2.5 ± 0.841 | 0.000 |
Walking ability | 5.27 ± 1.086 | 3.62 ± 0.706 | 0.000 |
Ability to perform activities of daily life | 4.02 ± 1.374 | 2.71 ± 0.892 | 0.000 |